HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX

被引:27
作者
Doitsh, G [1 ]
Shaul, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
关键词
HBV transcription; DNA-damage; cisplatin; HCC; pX and p53; HBV RNA half life;
D O I
10.1038/sj.onc.1203209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcription of hepatitis B Virus (HBV), an important risk factor of hepatocellular carcinoma (HCC), is controlled by cellular transcription activators including some of the cellular signaling targets, Consequently, HBV transcription rate changes in response to the cellular physiological conditions. In this report we investigated HBV gene expression and the role of physiological levels of the viral X protein (pX) under cisplatin induced genotoxic stress. We show that under these conditions the RNA level of an HBV mutant which does not express pX is sharply reduced. Studies revealed that transcription repression is responsible for the observed reduction in HBV RNA level. Repression of HBV transcription was obtained only in the p53 proficient cells. Furthermore, HBV transcription rate is recovered by the cotransfected p53 dominant negative plasmid, indicating that p53 is directly responsible for HBV transcription repression. Unexpectedly, p73, the recent p53 homologue, does not repress but rather activates HBV transcription. Interestingly, pX produced either by the HBV genome or by a cotransfected plasmid, relieves the p53 mediated repression. Collectively, these results attribute a physiological role to p53-inactivation by pX, and explain how pX may support HCC development.
引用
收藏
页码:7506 / 7513
页数:8
相关论文
共 59 条
[2]   Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases [J].
Benn, J ;
Su, F ;
Doria, M ;
Schneider, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (08) :4978-4985
[3]   ABNORMAL STRUCTURE AND EXPRESSION OF P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA [J].
BRESSAC, B ;
GALVIN, KM ;
LIANG, TJ ;
ISSELBACHER, KJ ;
WANDS, JR ;
OZTURK, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1973-1977
[4]  
Butz K, 1996, INT J CANCER, V68, P506, DOI 10.1002/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO
[5]  
2-2
[6]  
CHEONG JH, 1995, EMBO J, V14, P142
[7]   The hepatitis B virus X gene induces p53-mediated programmed cell death [J].
Chirillo, P ;
Pagano, S ;
Natoli, G ;
Puri, PL ;
Burgio, VL ;
Balsano, C ;
Levrero, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8162-8167
[8]   C-ABL HAS A SEQUENCE-SPECIFIC ENHANCER BINDING-ACTIVITY [J].
DIKSTEIN, R ;
HEFFETZ, D ;
BEN-NERIAH, Y ;
SHAUL, Y .
CELL, 1992, 69 (05) :751-757
[9]   THE HEPATITIS-B VIRUS HBX PROTEIN IS A DUAL-SPECIFICITY CYTOPLASMIC ACTIVATOR OF RAS AND NUCLEAR ACTIVATOR OF TRANSCRIPTION FACTORS [J].
DORIA, M ;
KLEIN, N ;
LUCITO, R ;
SCHNEIDER, RJ .
EMBO JOURNAL, 1995, 14 (19) :4747-4757
[10]   A SINGLE ELEMENT WITHIN THE HEPATITIS-B VIRUS ENHANCER BINDS MULTIPLE PROTEINS AND RESPONDS TO MULTIPLE STIMULI [J].
FAKTOR, O ;
BUDLOVSKY, S ;
BENLEVY, R ;
SHAUL, Y .
JOURNAL OF VIROLOGY, 1990, 64 (04) :1861-1863